LOX and neoplasm: Recently, a T4-Ce6-catalase (Cat)-lactate oxidase (Lox) (TCCL) biomimetic peroxisome was developed using T4 phage display technology for enhanced PDT, achieving high ROS generation efficiency and tumor inhibition rates, with low immunogenicity [238].